• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

与载脂蛋白C-II缺乏相关的高甘油三酯血症。

Hypertriglyceridemia associated with deficiency of apolipoprotein C-II.

作者信息

Breckenridge W C, Little J A, Steiner G, Chow A, Poapst M

出版信息

N Engl J Med. 1978 Jun 8;298(23):1265-73. doi: 10.1056/NEJM197806082982301.

DOI:10.1056/NEJM197806082982301
PMID:565877
Abstract

A 59-year-old man with severe hypertriglyceridemia and no post-heparin lipolytic activity was studied because of a marked fall in plasma triglyceride concentrations after a blood transfusion. An apolipoprotein activator (apolipoprotein C-II) for lipoprotein lipase could not be detected by polyacrylamide-gel electrophoresis of apoproteins, immunodiffusion of the plasma against anti-apolipoprotein CII or activation assays for lipoprotein lipase. Furthermore, the patient's triglyceride-rich lipoproteins would not serve as substrate for lipoprotein lipase. The patient had latent post-heparin lipolytic activity, which appeared after the addition of apolipoprotein CII to the post-heparin plasma. After a transfusion of 1 unit of plasma from a normal subject the patient's plasma triglycerides fell, within one day, from 1000 to 250 mg per deciliter and remained below preinfusion concentrations for six days. We conclude that this patient's hyperlipoproteinemia resulted from a deficiency of apolipoprotein C-II.

摘要

一名59岁男性,患有严重的高甘油三酯血症且无肝素后脂解活性,因输血后血浆甘油三酯浓度显著下降而接受研究。通过载脂蛋白的聚丙烯酰胺凝胶电泳、血浆与抗载脂蛋白CII的免疫扩散或脂蛋白脂肪酶的激活试验,均未检测到脂蛋白脂肪酶的载脂蛋白激活剂(载脂蛋白C-II)。此外,患者富含甘油三酯的脂蛋白不能作为脂蛋白脂肪酶的底物。该患者具有潜在的肝素后脂解活性,在肝素后血浆中加入载脂蛋白CII后出现。输注1单位正常受试者的血浆后,患者的血浆甘油三酯在一天内从每分升1000毫克降至250毫克,并在六天内维持在输注前浓度以下。我们得出结论,该患者的高脂蛋白血症是由载脂蛋白C-II缺乏引起的。

相似文献

1
Hypertriglyceridemia associated with deficiency of apolipoprotein C-II.与载脂蛋白C-II缺乏相关的高甘油三酯血症。
N Engl J Med. 1978 Jun 8;298(23):1265-73. doi: 10.1056/NEJM197806082982301.
2
Inheritance of apolipoprotein C-II deficiency with hypertriglyceridemia and pancreatitis.载脂蛋白C-II缺乏伴高甘油三酯血症和胰腺炎的遗传。
N Engl J Med. 1978 Dec 28;299(26):1421-4. doi: 10.1056/NEJM197812282992601.
3
Apolipoprotein C-II deficiency syndrome. Clinical features, lipoprotein characterization, lipase activity, and correction of hypertriglyceridemia after apolipoprotein C-II administration in two affected patients.载脂蛋白C-II缺乏综合征。两名患病患者的临床特征、脂蛋白特征、脂肪酶活性以及给予载脂蛋白C-II后高甘油三酯血症的纠正情况
J Clin Invest. 1986 Feb;77(2):520-7. doi: 10.1172/JCI112332.
4
C-II anapolipoproteinemia and severe hypertriglyceridemia. Report of a rare case with absence of C-II apolipoprotein isoforms and review of the literature.C-II脱辅基脂蛋白血症与重度高甘油三酯血症。1例罕见的C-II脱辅基脂蛋白亚型缺失病例报告及文献综述
Am J Med. 1984 Sep;77(3):457-62. doi: 10.1016/0002-9343(84)90102-5.
5
[Change in the apoproteins of very low density lipoproteins in the blood in hypertriglyceridemia].[高甘油三酯血症患者血液中极低密度脂蛋白载脂蛋白的变化]
Vopr Med Khim. 1979 Mar-Apr;25(2):185-92.
6
The plasma lipoproteins in familial chylomicronemia. Analysis by zonal ultracentrifugation.家族性乳糜微粒血症中的血浆脂蛋白。区带超速离心分析。
J Lab Clin Med. 1984 Nov;104(5):778-88.
7
Effects of slow-release bezafibrate on serum lipids, lipoproteins, apolipoproteins, and postheparin lipolytic activities in patients with type IV and type V hypertriglyceridemia.缓释苯扎贝特对IV型和V型高甘油三酯血症患者血脂、脂蛋白、载脂蛋白及肝素后脂解活性的影响。
Clin Ther. 1989 May-Jun;11(3):331-40.
8
Human apolipoprotein A-II determines plasma triglycerides by regulating lipoprotein lipase activity and high-density lipoprotein proteome.人载脂蛋白 A-II 通过调节脂蛋白脂肪酶活性和高密度脂蛋白蛋白质组来决定血浆甘油三酯。
Arterioscler Thromb Vasc Biol. 2010 Feb;30(2):232-8. doi: 10.1161/ATVBAHA.109.198226. Epub 2009 Nov 12.
9
Radioimmunoassay of human apolipoprotein CII. A study in normal and hypertriglyceridemic subjects.人载脂蛋白CII的放射免疫测定。对正常人和高甘油三酯血症患者的一项研究。
J Clin Invest. 1977 Jul;60(1):171-80. doi: 10.1172/JCI108753.
10
Studies of a variant very-low-density lipoprotein with an acquired deficiency of apolipoprotein C-II.载脂蛋白C-II获得性缺陷的变异极低密度脂蛋白的研究。
Clin Sci (Lond). 1982 Jan;62(1):93-100. doi: 10.1042/cs0620093.

引用本文的文献

1
Hypertriglyceridemia as a Key Contributor to Abdominal Aortic Aneurysm Development and Rupture: Insights From Genetic and Experimental Models.高甘油三酯血症作为腹主动脉瘤发生和破裂的关键因素:来自遗传和实验模型的见解
Circulation. 2025 Aug 5. doi: 10.1161/CIRCULATIONAHA.125.074737.
2
An overview of persistent chylomicronemia: much more than meets the eye.持续性乳糜微粒血症概述:远不止所见那么简单。
Curr Opin Endocrinol Diabetes Obes. 2025 Apr 1;32(2):75-88. doi: 10.1097/MED.0000000000000903. Epub 2025 Feb 10.
3
FXR-ApoC2 pathway activates UCP1-mediated thermogenesis by promoting the browning of white adipose tissues.
FXR-ApoC2通路通过促进白色脂肪组织的褐色化来激活UCP1介导的产热作用。
J Biol Chem. 2025 Mar;301(3):108181. doi: 10.1016/j.jbc.2025.108181. Epub 2025 Jan 10.
4
Directly Measuring Atherogenic Lipoprotein Kinetics in Zebrafish with the Photoconvertible LipoTimer Reporter.使用光转化脂质定时器报告基因直接测量斑马鱼中致动脉粥样硬化脂蛋白的动力学
bioRxiv. 2024 May 30:2024.05.29.596423. doi: 10.1101/2024.05.29.596423.
5
Zebrafish ApoB-Containing Lipoprotein Metabolism: A Closer Look.斑马鱼载脂蛋白 B 脂蛋白代谢:深入观察。
Arterioscler Thromb Vasc Biol. 2024 May;44(5):1053-1064. doi: 10.1161/ATVBAHA.123.318287. Epub 2024 Mar 14.
6
Developing a model to predict the early risk of hypertriglyceridemia based on inhibiting lipoprotein lipase (LPL): a translational study.基于抑制脂蛋白脂肪酶(LPL)建立预测高甘油三酯血症早期风险的模型:一项转化研究。
Sci Rep. 2023 Dec 19;13(1):22646. doi: 10.1038/s41598-023-49277-w.
7
Population serum proteomics uncovers a prognostic protein classifier for metabolic syndrome.人群血清蛋白质组学揭示代谢综合征的预后蛋白分类器。
Cell Rep Med. 2023 Sep 19;4(9):101172. doi: 10.1016/j.xcrm.2023.101172. Epub 2023 Aug 30.
8
Apolipoprotein C-II: a new look at an old protein.载脂蛋白C-II:对一种古老蛋白质的新认识。
Eur Heart J. 2023 Jul 1;44(25):2345-2347. doi: 10.1093/eurheartj/ehad237.
9
Tissue-specific pathway activities: A retrospective analysis in COVID-19 patients.组织特异性通路活性:COVID-19 患者的回顾性分析。
Front Immunol. 2022 Sep 15;13:963357. doi: 10.3389/fimmu.2022.963357. eCollection 2022.
10
Lipoprotein Lipase: Is It a Magic Target for the Treatment of Hypertriglyceridemia.脂蛋白脂肪酶:它是治疗高甘油三酯血症的神奇靶点吗?
Endocrinol Metab (Seoul). 2022 Aug;37(4):575-586. doi: 10.3803/EnM.2022.402. Epub 2022 Aug 29.